News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,632 Results
Type
Article (1604)
Company Profile (4)
Press Release (36024)
Section
Business (16386)
Career Advice (82)
Deals (2117)
Drug Delivery (1)
Drug Development (4896)
Employer Resources (1)
FDA (657)
Job Trends (818)
News (23265)
Policy (1193)
Tag
Academia (40)
Accelerated approval (1)
Allergies (2)
Alliances (1190)
ALS (4)
Alzheimer's disease (62)
Antibody-drug conjugate (ADC) (3)
Approvals (670)
Artificial intelligence (6)
Autoimmune disease (2)
Bankruptcy (8)
Best Places to Work (782)
BIOSECURE Act (2)
Biosimilars (2)
Biotechnology (3)
Bladder cancer (7)
Brain cancer (2)
Breast cancer (17)
Cancer (132)
Cardiovascular disease (6)
Career advice (82)
CAR-T (3)
Cell therapy (12)
Clinical research (4307)
Collaboration (14)
Compensation (5)
Complete response letters (1)
COVID-19 (68)
CRISPR (3)
C-suite (2)
Cystic fibrosis (4)
Data (198)
Diabetes (21)
Diagnostics (265)
Diversity, equity & inclusion (1)
Drug discovery (6)
Drug pricing (2)
Drug shortages (2)
Duchenne muscular dystrophy (5)
Earnings (14766)
Editorial (1)
Employer resources (1)
Events (5879)
Executive appointments (8)
FDA (775)
Frontotemporal dementia (1)
Funding (12)
Gene editing (5)
Generative AI (1)
Gene therapy (12)
GLP-1 (20)
Government (114)
Guidances (51)
Healthcare (876)
IgA nephropathy (5)
Immunology and inflammation (6)
Indications (5)
Infectious disease (71)
Inflammatory bowel disease (7)
Interviews (14)
IPO (1498)
IRA (1)
Job creations (93)
Job search strategy (60)
Layoffs (9)
Leadership (1)
Legal (168)
Liver cancer (4)
Lung cancer (26)
Lymphoma (12)
Manufacturing (6)
MASH (9)
Medical device (727)
Medtech (727)
Mergers & acquisitions (629)
Metabolic disorders (44)
Multiple sclerosis (7)
NASH (2)
Neurodegenerative disease (2)
Neuropsychiatric disorders (2)
Neuroscience (96)
NextGen: Class of 2025 (177)
Non-profit (92)
Obesity (17)
Opinion (5)
Ovarian cancer (6)
Pain (8)
Pancreatic cancer (5)
Parkinson's disease (5)
Patents (2)
Patient recruitment (3)
Peanut (1)
People (921)
Pharmaceutical (3)
Pharmacy benefit managers (2)
Phase I (895)
Phase II (1931)
Phase III (1747)
Pipeline (273)
Policy (4)
Postmarket research (186)
Preclinical (451)
Press Release (4)
Prostate cancer (9)
Radiopharmaceuticals (17)
Rare diseases (18)
Real estate (145)
Recruiting (1)
Regulatory (999)
Reports (2)
Research institute (44)
Resumes & cover letters (8)
Schizophrenia (14)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (2)
Startups (78)
Stomach cancer (2)
Supply chain (2)
The Weekly (1)
Vaccines (20)
Weight loss (8)
Women's health (1)
Date
Last 7 days (124)
Last 30 days (226)
Last 365 days (2288)
2025 (866)
2024 (2515)
2023 (2864)
2022 (3228)
2021 (3915)
2020 (2600)
2019 (2170)
2018 (1481)
2017 (1300)
2016 (998)
2015 (1309)
2014 (909)
2013 (519)
2012 (610)
2011 (796)
2010 (682)
Location
Africa (24)
Alabama (3)
Arizona (7)
Arkansas (1)
Asia (2356)
Australia (275)
California (459)
Canada (111)
China (25)
Colorado (16)
Connecticut (21)
Delaware (16)
Europe (4936)
Florida (57)
Georgia (17)
Idaho (1)
Illinois (37)
Indiana (44)
Japan (19)
Kansas (1)
Kentucky (3)
Louisiana (4)
Maine (11)
Maryland (67)
Massachusetts (308)
Michigan (17)
Minnesota (34)
Missouri (1)
Montana (2)
Nevada (1)
New Hampshire (9)
New Jersey (168)
New York (126)
North Carolina (46)
Northern California (221)
Ohio (9)
Oklahoma (1)
Pennsylvania (117)
South America (60)
Southern California (179)
Tennessee (7)
Texas (53)
United States (1702)
Utah (21)
Virginia (5)
Washington D.C. (3)
Washington State (42)
Wisconsin (2)
37,632 Results for "111".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
111, Inc. Regains Compliance with NASDAQ Requirement
February 11, 2025
·
3 min read
Press Releases
Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors
May 5, 2025
·
4 min read
Press Releases
111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
March 12, 2025
·
4 min read
Press Releases
111, Inc. Announces ADS Ratio Change
January 8, 2025
·
4 min read
Press Releases
Angitia Biopharmaceuticals Presents Data from Phase 1/2 Study of AGA111 at 2025 AAOS Annual Meeting
March 18, 2025
·
5 min read
Business
111, Inc. Announces First Quarter 2024 Unaudited Financial Results
111, Inc. today announced its unaudited financial results for the first quarter ended March 31, 2024.
May 23, 2024
·
21 min read
Press Releases
111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow
February 20, 2025
·
2 min read
Press Releases
BioRay’s ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA
February 10, 2025
·
2 min read
BioCapital
Zephyr AI Raises $111 Million in Series A Financing
Zephyr AI, Inc. today announced it has successfully closed a $111 million Series A funding round with participation from Revolution Growth, Eli Lilly & Co.
March 13, 2024
·
4 min read
Press Releases
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
November 27, 2024
·
22 min read
1 of 3,764
Next
